KBI Biopharma, Inc., a JSR Life Sciences company, appointed Maggie Chen senior vice president and site head of the Patriot Park mammalian cGMP manufacturing facility in Durham, NC.

Chen brings over 20 years of biopharmaceutical experience as a leader in manufacturing, science & technologies, quality, and engineering. Chen will oversee the site’s day-to-day operations.

Prior to joining KBI, Chen built and led high-performing teams at Johnson & Johnson, Spectranetics (now Philips), and Novartis. She most recently transitioned from her role at AGC Biologics as senior director of manufacturing for cell and gene therapy, Longmont site and interim engineering head for Colorado, to spearhead KBI’s commercial mammalian facility in North Carolina where she leverages her extensive background in manufacturing, engineering, and automation.

“I am very happy to welcome Maggie to KBI,” Tony Fraij, KBI Biopharma COO. “I am confident that her passion for cross-functional collaboration and expertise in operational readiness and program management will be valued at the facility, across the KBI network, and in customer interactions. Maggie will play a pivotal role in shaping the trajectory of the Patriot Park site as it continues to evolve and expand to meet the needs of our current and future customers.”

“I am incredibly grateful for the opportunity to join the KBI team at Patriot Park,” said Chen. “KBI has built a strong reputation with a high customer satisfaction rating, and this location is primed to continue to deliver at an exceptional level for our commercial customers.”